KLRA insider buying and SEC filings, explained
Kailera Therapeutics, Inc. · CIK 2096997
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$326.8M
Insiders who bought
5
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Apr 20, 2026 | Purchase (code P) | Roderick Wong (10% owner) bought 500,000 shares indirectly at $16.00 ($8.0M), reported as a purchase (code P). Indirect holdings up 5% to 10,776,820 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Apr 22, 2026 |
| Apr 20, 2026 | Purchase (code P) | BAIN CAPITAL INVESTORS LLC (10% owner) bought 8,398,438 shares indirectly at $16.00 ($134.4M), reported as a purchase (code P). Indirect holdings up 47% to 26,255,581 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Apr 20, 2026 |
| Apr 20, 2026 | Purchase (code P) | Bain Capital Life Sciences Investors, LLC (10% owner) bought 1,562,500 shares indirectly at $16.00 ($25.0M), reported as a purchase (code P). Indirect holdings up 7% to 22,583,268 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Apr 20, 2026 |
| Apr 20, 2026 | Purchase (code P) | Adam Koppel (Director and 10% owner) bought 1,562,500 shares indirectly at $16.00 ($25.0M), reported as a purchase (code P). Indirect holdings up 7% to 22,583,268 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
| Apr 20, 2026 | Purchase (code P) | Andrew T. Kaplan (Director and 10% owner) bought 8,398,438 shares indirectly at $16.00 ($134.4M), reported as a purchase (code P). Indirect holdings up 47% to 26,255,581 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
20 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
5 insiders bought in 30 days
$326.8M in purchases since Apr 20, 2026 · Purchases traded Apr 20, 2026 to Apr 20, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Andrew T. Kaplan (Director) | $134.4M | Apr 20, 2026 | SEC filing |
| Adam Koppel (Director) | $25.0M | Apr 20, 2026 | SEC filing |
| Bain Capital Life Sciences Investors, LLC (10% owner) | $25.0M | Apr 20, 2026 | SEC filing |
| BAIN CAPITAL INVESTORS LLC (10% owner) | $134.4M | Apr 20, 2026 | SEC filing |
| Roderick Wong (10% owner) | $8.0M | Apr 20, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow KLRA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.